Thyrocare Technologies Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "Press release on the unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2025.".
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Thyrocare Technologies has shared a press release dated January 28, 2026, covering its unaudited financial results for the third quarter (Q3) and the nine-month period ending December 31, 2025. The results are presented on both a standalone (Thyrocare only) and consolidated (including subsidiaries) basis. This is a standard quarterly earnings disclosure that all listed companies must file with the exchange. The actual detailed numbers and performance metrics would be in the press release document itself, which is referenced here.
This announcement itself is a routine filing obligation and does not directly move the stock. Investors should look at the actual financial numbers in the linked press release for revenue, profit, and margin trends that could influence the stock's near-term direction.